John Robinette in Pine Bluff, Arkansas

Medical School: Des Moines University Of Osteopathic Medicine And Health Sciences
Graduation Year: 1996
The Primary Medical Specialty for John Robinette is listed as: Podiatry
Approximate Years of Experience: 28
PAC (PECOS ID)#: 3870761075
NPI #: 1649254228
NPI Created On: 12/06/2005
NPI Last Updated Listed as: 10/24/2017
Primary Taxonomy Code: 213ES0131X
License Number:
165
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• QualChoice Life & Health Insurance Company, Inc.
• USAble Mutual Insurance Company
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: ENGL, English.

Services and Procedures include:

1. Removal of single thickened skin growth
2. Removal of tissue from 1 to 5 finger or toe nails
3. Removal of tissue from 6 or more finger or toe nails
4. Separation of nail plate from nail bed
5. Removal of nail
6. Injections of tendon sheath, ligament, or muscle membrane
7. X-ray of foot, minimum of 3 views
8. Removal of tissue from wounds per session
9. Removal of tissue from wounds per session
10. New patient office or other outpatient visit, typically 20 minutes
11. New patient office or other outpatient visit, typically 30 minutes
12. Established patient office or other outpatient visit, typically 10 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient visit, typically 15 minutes
15. Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a)
16. Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i
17. Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
18. Injection, methylprednisolone acetate, 40 mg